EP0974345A2 — Capsule sealing system
Assigned to MW Encap Ltd · Expires 2000-01-26 · 26y expired
What this patent protects
A solution for sealing capsules comprises a mixture of the chemical material of the capsule, a solute elevating the thermal gelation temperature, a gelling agent and a hydrating agent. The properties of the solution can be altered by the inclusion of other reagents, for example p…
USPTO Abstract
A solution for sealing capsules comprises a mixture of the chemical material of the capsule, a solute elevating the thermal gelation temperature, a gelling agent and a hydrating agent. The properties of the solution can be altered by the inclusion of other reagents, for example plasticisers. The solution is produced by mixing a first subordinate solution, which contains the material of the capsule and the solute elevating the thermal gelation temperature, and a second subordinate solution, which contains the gelling agent and the hydrating agent.
Drugs covered by this patent
- OxyContin (oxycodone) · Purdue Pharma
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.